Hepatic Hydrothorax

Hepatic hydrothorax is a transudative pleural effusion that occurs in patients with advanced cirrhosis, usually right‑sided, due to diaphragmatic defects. It worsens breathlessness and signals decompensated portal hypertension.

Overview

In cirrhosis, high portal pressure forces ascitic fluid through microscopic diaphragmatic pores into the pleural space, most often the right hemithorax. The fluid is a transudate with low protein and lactate dehydrogenase.

• Occurs in ~5‑10% of cirrhotics with ascites
• Right‑sided in >85% of cases
• Absence of primary lung disease

Key concepts

Diagnosis rests on clinical suspicion, pleural fluid analysis, and exclusion of cardiac or pulmonary causes. Severity is staged by volume of effusion and impact on respiration.

• Chest X‑ray: Confirms effusion side and size; if unavailable, bedside percussion and auscultation can estimate fluid
• Thoracentesis fluid analysis: Distinguishes transudate (protein <3 g/dL, LDH <0.6 × serum) from exudate; rules out infection or malignancy
• Ultrasound of abdomen: Detects ascites and diaphragmatic defects; if ultrasound not available, clinical exam for shifting dullness and fluid wave
• Serum‑ascites albumin gradient (SAAG): SAAG ≥1.1 g/dL supports portal hypertension as the driver

• Diagnostic criteria: cirrhosis + pleural effusion + transudate + no other cause
• Stage I: small, asymptomatic; Stage II: moderate, dyspnoea on exertion; Stage III: large, refractory dyspnoea

Clinical relevance

Large hydrothorax can precipitate hypoxia, respiratory failure, and infection (spontaneous bacterial empyema). It also reflects severe portal hypertension, prompting evaluation for liver transplantation.

• Dyspnoea out of proportion to ascites volume
• Pleural fluid that re‑accumulates rapidly after drainage
• Risk of empyema when pleural fluid protein >1 g/dL

Exam pearls

Focus on bedside assessment and rapid decision‑making when resources are limited.

• Percussion: dullness over lower lung fields, resonant above – suggests fluid
• Auscultation: decreased breath sounds, egophony above fluid level
• Shift of dullness with patient position confirms free fluid

Management

Treat the underlying portal hypertension, control fluid accumulation, and consider procedural options when medical therapy fails.

• Serial chest examinations: Monitors re‑accumulation; if effusion recurs within 24‑48 h, consider TIPS or pleurodesis
• Albumin infusion after large thoracentesis: Prevents circulatory dysfunction when >1 L removed; if albumin unavailable, monitor vitals closely

• Salt restriction <2 g/day and diuretics (spironolactone + furosemide) to reduce ascites
• Therapeutic thoracentesis for symptomatic relief; limit to 1‑1.5 L at a time to avoid re‑expansion pulmonary oedema
• TIPS (transjugular intra‑hepatic portosystemic shunt) if refractory and facilities exist
• Consider liver transplantation for definitive cure

Often confused with

Conditions that also produce unilateral pleural effusion in cirrhotics.

• Congestive heart failure – exudative or transudative but bilateral and associated with elevated JVP
• Tuberculous pleuritis – lymphocytic exudate, high protein, common in East Africa
• Spontaneous bacterial empyema – infected hydrothorax; requires antibiotics

Where results can mislead

Pleural fluid protein may be modestly raised in hepatic hydrothorax, mimicking an exudate.

• Rely on SAAG and clinical context rather than protein alone
• Chest X‑ray may miss small right‑sided effusions; use bedside percussion

Questions an examiner may ask

• A cirrhotic patient presents with sudden right‑sided dyspnoea and a large pleural effusion – what is your next diagnostic step and why? — Perform bedside thoracentesis; fluid analysis will confirm a transudate and exclude infection.
• How does hepatic hydrothorax differ from congestive heart failure effusion on examination? — Hydrothorax is usually unilateral, right‑sided, with absent peripheral oedema and normal JVP.
• A patient with known hepatic hydrothorax has recurrent effusions despite optimal diuretics – what definitive treatment is indicated in low‑resource settings? — Consider TIPS if interventional radiology is available; otherwise evaluate for liver transplantation.
• What feature on pleural fluid analysis most strongly supports a hepatic origin? — SAAG ≥1.1 g/dL indicating portal hypertension‑related transudate.
• Why is a chest tube contraindicated in hepatic hydrothorax? — It leads to massive protein loss, risk of infection, and re‑expansion pulmonary oedema without addressing the underlying leak.
• In a resource‑limited hospital without ultrasound, how can you confirm a hepatic hydrothorax bedside? — Use percussion and auscultation to detect shifting dullness, and perform diagnostic thoracentesis to analyse fluid.
• What are red‑flag signs that a hepatic hydrothorax has become infected? — Fever, pleuritic chest pain, leukocytosis, and pleural fluid neutrophil count >250 cells/µL.
• Explain why sodium restriction is essential in managing hepatic hydrothorax. — Reducing sodium limits ascitic fluid formation, decreasing the pressure driving fluid across the diaphragm.

When to seek help

• Sudden increase in dyspnoea with fever – possible empyema
• Rapid re‑accumulation after thoracentesis causing respiratory compromise
• Hypotension or altered mental status after large fluid removal

Quick questions

Why is hepatic hydrothorax usually right‑sided?

The right hemidiaphragm is thinner and more prone to microscopic defects, allowing ascitic fluid to pass more easily.

Can diuretics alone cure hepatic hydrothorax?

They may reduce ascites but often fail to stop pleural fluid leak; procedural intervention is needed for large symptomatic effusions.

Is chest tube drainage recommended?

No, because continuous drainage can cause protein loss, infection, and re‑expansion pulmonary oedema; thoracentesis is preferred.